Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Rubinstein Julie sold 35,643 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Oct 14 to Oct 16, 2026 · Filed Oct 16, 2026
From Oct 14 to Oct 16, 2026, Rubinstein Julie (President and COO) sold 35,643 Adaptive Biotechnologies Corporation shares at an average US$25.18 for US$897K under a trading plan, leaving 377,802 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 35,643 shares
- Price
- US$25.18 average (US$24.21 to US$25.82)
- Value
- US$897K
- Holding after
- 377,802 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | Common Stock | Option exercise | 11,881 | US$12.14 | 389,683 | Direct |
| Oct 14, 2026 | Common Stock | Sale | 6,781 | US$25.57 | 382,902 | Direct |
| Oct 14, 2026 | Common Stock | Sale | 5,100 | US$25.82 | 377,802 | Direct |
| Oct 15, 2026 | Common Stock | Option exercise | 11,881 | US$12.14 | 389,683 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 11,881 | US$25.61 | 377,802 | Direct |
| Oct 16, 2026 | Common Stock | Option exercise | 11,881 | US$12.14 | 389,683 | Direct |
| Oct 16, 2026 | Common Stock | Sale | 11,581 | US$24.21 | 378,102 | Direct |
| Oct 16, 2026 | Common Stock | Sale | 300 | US$25.45 | 377,802 | Direct |
Source
Download original · View original at SEC
Related
- Adaptive Biotechnologies Corporation
- Rubinstein Julie
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026
- Form 4 · Rubinstein Julie · Apr 29, 2026
- Form 4 · Rubinstein Julie · Apr 24, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Lo Francis · Oct 5, 2026
- Form 4 · Lo Francis · Sep 18, 2026
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026